Tengfu Medical
Latest round
- Series A
Last raised
- Mar 2022
Total raised
- $16M
Investors
- 7
About Tengfu Medical
Established in 2020, Tengfu Medical is a Medical device developer that provides R&D, production and sales of pulmonary embolism intervention medical devices. The company is mainly involved in the field of two main disease areas include pulmonary embolism and deep vein thrombosis. The company specializes in the development of pulmonary artery thrombosis systems. The company self-developed pulmonary artery thrombosis systems has the function of remove bleeding clots, restore blood flow to the pulmonary vessels and save lives.
Who invested in Tengfu Medical
7 investors across 3 rounds
See all investors in Tengfu Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tengfu Medical
Who invested in Tengfu Medical?
Tengfu Medical has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tengfu Medical raised?
Tengfu Medical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Tengfu Medical last raise money?
Tengfu Medical's most recent round on record is a Series A, in Mar 2022.
What does Tengfu Medical do?
Established in 2020, Tengfu Medical is a Medical device developer that provides R&D, production and sales of pulmonary embolism intervention medical devices.
Where is Tengfu Medical headquartered?
Tengfu Medical is headquartered in Shenzhen, China.
Which VCs invest in companies like Tengfu Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Tengfu Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Tengfu Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.